Table 3b.
Significantly affected genes associated with extracellular matrix.
| Gene title | Gene symbol | p-Value | Fold-change (S vs. C)a |
|---|---|---|---|
| aggrecan | ACAN | 0.03 | − 1.26 |
| ADAM metallopeptidase with thrombospondin type 1 motif, 1 | ADAMTS1 | 0.03 | 2.56 |
| ADAM metallopeptidase with thrombospondin type 1 motif, 6 | ADAMTS6 | 0.05 | 1.15 |
| hyaluronan and proteoglycan link protein 1 | HAPLN1 | 0.05 | − 1.14 |
| leucine proline-enriched proteoglycan (leprecan) 1 | LEPRE1 | 0.04 | − 1.21 |
| lumican | LUM | 0.03 | − 1.12 |
| matrix metallopeptidase 16 (membrane-inserted) | MMP16 | 0.02 | − 1.17 |
| matrix metallopeptidase 25 | MMP25 | 0.02 | − 1.14 |
| matrix metallopeptidase 24 (membrane-inserted) | MMP24 | 0.01 | 1.22 |
| sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) | SPAM1 | 0.04 | 1.15 |
| sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | SPOCK3 | 0.01 | 1.11 |
| spondin 1, extracellular matrix protein | SPON1 | 0.02 | 2.14 |
| versican | VCAN | 0.04 | − 1.13 |
a
S = schizophrenia; C = control.